trending Market Intelligence /marketintelligence/en/news-insights/trending/husm3qsb_-a_fffvgomqjq2 content esgSubNav
In This List

ImmunoGen board member to step down

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


ImmunoGen board member to step down

ImmunoGen Inc. said its board member Daniel Junius will not stand for re-election at the upcoming annual meeting of the company.

Junius is the former president and CEO of the Waltham, Mass.-based company that develops therapies for cancer.